Lisinopril and Hydrochlorothiazide
- Product NDC
- 60760-861
- 11-digit product format
- 607600861
- Labeler code
- 60760
- Product ID
- 60760-861_bc911eb3-52da-c42d-e053-2995a90a02b4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2021-02-24
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-861-90 | 60760086190 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-861-90) | 90 tablet | 2021-02-24 | 0000-00-00 | No | No | Current |